Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy

Bone

Volumn 25, Issue 3, 1999, Pages 349-353

  Peris, P ^a   Alvarez, L ^a   Monegal, A ^a   Guanabens N ^a   Duran M ^a   Pons, F ^a   Martinez De Osaba M J ^a   Echevarria M ^a   Ballesta, A M ^a   Munoz Gomez J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Cross links; Estrogens; Propeptides; Remodeling; Telopeptides

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; ESTROGEN; OSTEOCALCIN; PROCOLLAGEN;

ADULT; ARTICLE; BONE ATROPHY; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS;

ACID PHOSPHATASE; ADMINISTRATION, CUTANEOUS; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; BONE RESORPTION; COLLAGEN; COLLAGEN TYPE I; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROXYPROLINE; ISOENZYMES; MENOPAUSE, PREMATURE; MIDDLE AGED; OSTEOCALCIN; OVARIECTOMY; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN;

EID: 0032866653     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00175-1     Document Type: Article

References (26)

1. Aitken J.M., Hart D.M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 3:1973;515-518.
2. Alvarez L., Peris P., Pons F., et al. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Arthritis Rheum. 40:1997;461-468.
3. Amama E.A., Taga M., Minaguchi H. The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide an N-telopeptide the predictive value of biochemical markers of bone turnover . J Clin Endocrinol Metab. 83:1998;333-338.
4. Bonde M., Garnero P., Fledelius C., Qvist P., Delmas P.D., Christiansen C. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res. 12:1997;1028-1034.
5. Bonde M., Qvist P., Fledelius C., Riis B.J., Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps) follow-up on hormone replacement therapy and osteoporosis risk assessment . J Clin Endocrinol Metab. 80:1995;864-868.
6. Cantatore F.P., Cicinelli E., Galantino P., et al. Evaluation of bone turnover and bone mass during tapering estrogen therapy a preliminary report . Arthritis Rheum. 38:1995;292-294.
7. Chesnut C.H. III, Bell N.H., Clark G.S., et al. Hormone replacement therapy in postmenopausal women urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density . Am J Med. 102:1997;29-37.
8. Christgau S., Rosenquist C., Alexandersen P., et al. Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem. 44:1998;2290-2300.
9. Ebeling P.R., Atley L.M., Guthrie J.R., et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 81:1996;3366-3371.
10. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease correlation with bone histomorphometry . J Bone Miner Res. 8:1993;127-132.
11. Fledelius C., Johnsen A.H., Cloos P.A.C., Bonde M., Qvist P. Characterization of urinary degradation products derived from type I collagen. J Biol Chem. 272:1997;9755-9763.
12. Garnero P., Delmas P.D. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1993;1046-1053.
13. Garnero P., Fledelius C., Gineyts E., Serre C.M., Vignot E., Delmas P. Decreased β-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. J Bone Miner Res. 12:1997;1407-1415.
14. Garnero P., Gineyts E., Arbault P., Christiansen C., Delmas P.D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res. 10:1995;641-649.
15. Gertz B.J., Shao P., Hanson D.A., et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res. 9:1994;135-142.
16. Gorai Y., Taguchui Y., Chai O., Nakayama M., Minaguchi H. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women correlation with other markers of bone turnover . Calcif Tissue Int. 60:1997;317-322.
17. Hanson D.A., Weis M.A.E., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption quantitation of type collagen cross-linked N-telopeptides in urine . J Bone Miner Res. 7:1992;1251-1258.
18. Kleerekoper M. Biochemical markers of bone turnover. Am J Med Sci. 312:1996;270-277.
19. Linkhart S.G., Linkhart T.A., Taylor A.K., Wergedal J.E., Bettica P., Baylink D.J. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen application for evaluation of bone formation . Clin Chem. 39:1993;2254-2258.
20. Riis B.J. Biochemical markers of bone turnover II diagnosis, prophylaxis, and treatment of osteoporosis . Am J Med. 95:(Suppl. 5A):1993;17-21.
21. Risteli J., Niemi S., Kauppila S., Melkko J., Risteli L. Collagen propeptides as indicators of collagen assembly. Acta Orthop Scand. 60:(Suppl. 265):1995;183-188.
22. Rosen C.J., Chesnut C.H. III, Mallinak N.J.S. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 82:1997;1904-1910.
23. Rosenquist C., Fledelius C., Christgau S., et al. Serum CrossLaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem. 44:1998;2281-2289.
24. Satoh Y., Soeda Y., Dokou S. Analysis of relationships between sex hormone dynamics and bone metabolism and changes in bone mass in surgically induced menopause. Calcif Tissue Int. 57:1995;258-266.
25. Seibel M.J., Cosman F., Shen V., et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res. 8:1993;881-889.
26. Tobias J.H., Compston J.E. Does estrogen stimulate osteoblast function in postmenopausal women? Bone. 24:1999;121-124.